A spider plot of tumor measurement changes over time in all 30 patients. aPatients had overall PD with < 20% increase on target lesions but had new nontarget lesions. bPatients had rapid clinical deterioration before a restaging imaging study could be performed, who are documented a 21% tumor increase. cOne patient was still on treatment at the last updated date on May 24, 2022. PD, progressive disease; PR, partial response; SD, stable disease.